0001179110-18-013077.txt : 20181121
0001179110-18-013077.hdr.sgml : 20181121
20181121161247
ACCESSION NUMBER: 0001179110-18-013077
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181119
FILED AS OF DATE: 20181121
DATE AS OF CHANGE: 20181121
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Knowlton Calvin H
CENTRAL INDEX KEY: 0001685833
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37888
FILM NUMBER: 181198341
MAIL ADDRESS:
STREET 1: 228 STRAWBRIDGE DRIVE
STREET 2: SUITE 100
CITY: MOORESTOWN
STATE: NJ
ZIP: 08057
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Tabula Rasa HealthCare, Inc.
CENTRAL INDEX KEY: 0001651561
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389]
IRS NUMBER: 465726437
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 228 STRAWBRIDGE DRIVE
STREET 2: SUITE 100
CITY: MOORESTOWN
STATE: NJ
ZIP: 08057
BUSINESS PHONE: 866-648-2767
MAIL ADDRESS:
STREET 1: 228 STRAWBRIDGE DRIVE
STREET 2: SUITE 100
CITY: MOORESTOWN
STATE: NJ
ZIP: 08057
4
1
edgar.xml
FORM 4 -
X0306
4
2018-11-19
0
0001651561
Tabula Rasa HealthCare, Inc.
TRHC
0001685833
Knowlton Calvin H
228 STRAWBRIDGE DRIVE
SUITE 100
MOORESTOWN
NJ
08057
1
1
0
0
Chief Executive Officer
Common Stock
2018-11-19
4
S
0
1066
59.71
D
834285
I
Held by spouse.
Common Stock
2018-11-19
4
S
0
1636
60.76
D
832649
I
Held by spouse.
Common Stock
2018-11-19
4
S
0
3598
61.67
D
829051
I
Held by spouse.
Common Stock
2018-11-19
4
S
0
800
62.63
D
828251
I
Held by spouse.
Common Stock
2018-11-19
4
S
0
400
64.28
D
827851
I
Held by spouse.
Common Stock
2018-11-19
4
S
0
500
65.32
D
827351
I
Held by spouse.
Common Stock
851399
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Orsula V. Knowlton on May 15, 2018.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $59.31 to $60.30, inclusive. The reporting person undertakes to provide to Tabula Rasa HealthCare, Inc., any security holder of Tabula Rasa HealthCare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in footnotes (2), (3), (4), (5), (6) and (7) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $60.31 to $61.25, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $61.32 to $62.07, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $62.29 to $62.84, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $63.86 to $64.53, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $65.00 to $65.94, inclusive.
The sales aggregated in Row 5 of Table I are not matchable under Section 16(b) of the Securities Exchange Act of 1934 against purchases at lower prices by the reporting person on November 12, 2018 because such purchases were previously matched with sales on September 7, 2018 at higher sales prices, and the reporting person has already paid to Tabula Rasa Healthcare, Inc. the full amount of profit realized in connection with the previous short-swing transactions. Thus, no further disgorgement under Section 16(b) would result from the transactions disclosed herein.
The sales aggregated in Row 6 of Table I are not matchable under Section 16(b) of the Securities Exchange Act of 1934 against purchases at lower prices by the reporting person on November 12, 2018 because such purchases were previously matched with sales on September 7, 2018 at higher sales prices, and the reporting person has already paid to Tabula Rasa Healthcare, Inc. the full amount of profit realized in connection with the previous short-swing transactions. Thus, no further disgorgement under Section 16(b) would result from the transactions disclosed herein.
/s/ Brian W. Adams, by Power of Attorney
2018-11-21